FDA ban on Juul Lab’s electronic cigarettes suspended by an appeals court
The brand Juul Laabs breathes after the decision of an appeals court that put on hold temporarily Friday, June 24 the decision of the U.S. agency in charge of health (FDA) to ban the sale in the United States of all electronic cigarettes brand Juul Laabs.
In any case, the company Juul Laabs had warned that it would file a motion for an emergency adjournment, before possibly preparing a stronger appeal.
Judges at a Washington appeals court decided to stay the decision to give themselves more time to consider Juul Labs’ request, which is not an indication of the merits of the case, they said in their ruling, accessed by AFP.
The FDA found that the start-up, which helped make electronic cigarettes popular with its USB-shaped vaporizers and its fruity-flavoured nicotine refills, had not provided enough data on its products to be able to assess “potential toxicological risks”.
She, therefore, decided to order the ban on the marketing of its products and the withdrawal of those already in stores. Juul Labs claims to have “provided sufficient information and data” to resolve all the issues raised by the agency.
It had warned as early as Thursday, June 23, that it planned to seek a stay of the decision and explore all options available to it, including an appeal. According to the Wall Street Journal, the company is also exploring with its legal advisors the possibility of filing for bankruptcy protection if the FDA’s ban is upheld. The FDA said in a message that it did not comment on possible or pending proceedings.